Cargando…

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing

BACKGROUND: The current diagnostic standard for coronavirus disease 2019 (COVID-19) is reverse transcriptase-polymerase chain reaction (RT-PCR) testing with nasopharyngeal (NP) swabs. The invasiveness and need for trained personnel make the NP technique unsuited for repeated community-based mass scr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boutros, Jacques, Benzaquen, Jonathan, Marquette, Charles Hugo, Ilié, Marius, Labaky, Mickelina, Benchetrit, Didier, Lavrut, Thibaut, Leroy, Sylvie, Chemla, Richard, Carles, Michel, Tanga, Virginie, Maniel, Charlotte, Bordone, Olivier, Allégra, Maryline, Lespinet, Virginie, Fayada, Julien, Griffonnet, Jennifer, Hofman, Véronique, Hofman, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474486/ https://www.ncbi.nlm.nih.gov/pubmed/34877351 http://dx.doi.org/10.1183/23120541.00396-2021

Ejemplares similares

A rapid near-patient RT-PCR test for suspected COVID-19: a study of the diagnostic accuracy
por: Hofman, Paul, et al.
Publicado: (2021)

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
por: Hofman, Paul, et al.
Publicado: (2021)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
por: Hofman, Paul, et al.
Publicado: (2022)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
por: Ilié, Marius, et al.
Publicado: (2023)

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution
por: Heeke, Simon, et al.
Publicado: (2020)

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer
por: Khatir, Wassila, et al.
Publicado: (2022)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
por: Ilié, Marius, et al.
Publicado: (2022)

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
por: Heeke, Simon, et al.
Publicado: (2018)

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
por: Lassalle, Sandra, et al.
Publicado: (2020)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
por: Heeke, Simon, et al.
Publicado: (2021)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
por: Martel, Arnaud, et al.
Publicado: (2023)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
por: Long-Mira, Elodie, et al.
Publicado: (2018)

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay
por: Heeke, Simon, et al.
Publicado: (2021)

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer
por: Ilie, Marius, et al.
Publicado: (2017)

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC
por: Hofman, Véronique, et al.
Publicado: (2022)

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients
por: Heeke, Simon, et al.
Publicado: (2019)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
por: Pujol, Nina, et al.
Publicado: (2022)

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
por: Long-Mira, Elodie, et al.
Publicado: (2022)

Escape of SARS-CoV-2 Variant Omicron to Mucosal Immunity in Vaccinated Subjects
por: Martinuzzi, Emanuela, et al.
Publicado: (2022)

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables
por: BOUTROS, Jacques, et al.
Publicado: (2019)

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
por: Bontoux, Christophe, et al.
Publicado: (2022)

Multidisciplinary management of tracheobronchial injury
por: Boutros, Jacques, et al.
Publicado: (2022)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
por: Hofman, Véronique, et al.
Publicado: (2018)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
por: Ilié, Marius, et al.
Publicado: (2022)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
por: Hofman, Véronique, et al.
Publicado: (2019)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
por: Bontoux, Christophe, et al.
Publicado: (2023)

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA
por: Washetine, Kevin, et al.
Publicado: (2018)

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients
por: Ilie, Marius, et al.
Publicado: (2017)

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France
por: Leroy, Sylvie, et al.
Publicado: (2017)

Mutations in KMT2C, BCOR and KDM5C Predict Response to Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Liu, Dingxie, et al.
Publicado: (2022)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023)

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
por: Benzaquen, Jonathan, et al.
Publicado: (2019)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
por: Washetine, Kevin, et al.
Publicado: (2018)

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease
por: Ilie, Marius, et al.
Publicado: (2014)

European Real-World Assessment of the Clinical Validity of a CE-IVD Panel for Ultra-Fast Next-Generation Sequencing in Solid Tumors
por: Normanno, Nicola, et al.
Publicado: (2023)

P2RX7B is a new theranostic marker for lung adenocarcinoma patients
por: Benzaquen, Jonathan, et al.
Publicado: (2020)

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
por: Ilie, M, et al.
Publicado: (2014)

Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC
por: Sanfiorenzo, Céline, et al.
Publicado: (2013)

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma
por: Ilié, Marius, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qucbk5faec3lqkc3i7isvckn5b